Jaafar C, Aguiar R
Proc Natl Acad Sci U S A. 2024; 121(46):e2317847121.
PMID: 39495907
PMC: 11572932.
DOI: 10.1073/pnas.2317847121.
Hu H, Li Z, Xie X, Liao Q, Hu Y, Gong C
Genes Dis. 2024; 11(4):101011.
PMID: 38560499
PMC: 10978549.
DOI: 10.1016/j.gendis.2023.04.038.
Chen X, Gong C
Comb Chem High Throughput Screen. 2024; 27(15):2301-2307.
PMID: 38485681
DOI: 10.2174/0113862073281598240227072839.
Wang H, Han Y, Qian P
Adv Exp Med Biol. 2024; 1442:29-44.
PMID: 38228957
DOI: 10.1007/978-981-99-7471-9_3.
Liu R, Zhao E, Yu H, Yuan C, Abbas M, Cui H
Signal Transduct Target Ther. 2023; 8(1):310.
PMID: 37620312
PMC: 10449936.
DOI: 10.1038/s41392-023-01528-y.
RNA modification: mechanisms and therapeutic targets.
Qiu L, Jing Q, Li Y, Han J
Mol Biomed. 2023; 4(1):25.
PMID: 37612540
PMC: 10447785.
DOI: 10.1186/s43556-023-00139-x.
The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches.
Gruber E, Kats L
Biochem Soc Trans. 2023; 51(4):1675-1686.
PMID: 37526143
PMC: 10586776.
DOI: 10.1042/BST20230017.
The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches.
Deacon S, Walker L, Radhi M, Smith S
Cancers (Basel). 2023; 15(13).
PMID: 37444417
PMC: 10340774.
DOI: 10.3390/cancers15133307.
RNA modifications in hematological malignancies.
Jin Z, MacPherson K, Liu Z, Vu L
Int J Hematol. 2023; 117(6):807-820.
PMID: 36929506
DOI: 10.1007/s12185-023-03576-0.
High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia.
Arza-Apalategi S, Heuts B, Dooijes M, Gilissen D, van der Heijden A, Jansen J
Leukemia. 2023; 37(4):901-904.
PMID: 36807648
DOI: 10.1038/s41375-023-01844-w.
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
Ge T, Gu X, Jia R, Ge S, Chai P, Zhuang A
Cancer Commun (Lond). 2022; 42(11):1049-1082.
PMID: 36266736
PMC: 9648395.
DOI: 10.1002/cac2.12374.
m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.
Xu Z, Wen X, Zhang Y, Jin Y, Ma J, Gu Y
Front Genet. 2022; 13:948079.
PMID: 36035161
PMC: 9399688.
DOI: 10.3389/fgene.2022.948079.
Multivariate Analysis of RNA Chemistry Marks Uncovers Epitranscriptomics-Based Biomarker Signature for Adult Diffuse Glioma Diagnostics.
Relier S, Amalric A, Attina A, Koumare I, Rigau V, Burel Vandenbos F
Anal Chem. 2022; 94(35):11967-11972.
PMID: 35998076
PMC: 9453740.
DOI: 10.1021/acs.analchem.2c01526.
FTO Regulates Apoptosis in CPB2-Treated IPEC-J2 Cells by Targeting Caspase 3 Apoptotic Protein.
Yang J, Zhang J, Gao X, Luo R, Xie K, Wang W
Animals (Basel). 2022; 12(13).
PMID: 35804542
PMC: 9264887.
DOI: 10.3390/ani12131644.
Epigenetic regulation of hematopoietic stem cell homeostasis.
Jiang P, Wang H, Zheng J, Han Y, Huang H, Qian P
Blood Sci. 2022; 1(1):19-28.
PMID: 35402787
PMC: 8974946.
DOI: 10.1097/BS9.0000000000000018.
MYC, mitochondrial metabolism and O-GlcNAcylation converge to modulate the activity and subcellular localization of DNA and RNA demethylases.
Lin A, Qiu Z, Ethiraj P, Sasi B, Jaafar C, Rakheja D
Leukemia. 2022; 36(4):1150-1159.
PMID: 34997181
PMC: 8983447.
DOI: 10.1038/s41375-021-01489-7.
Epitranscriptomics in Hematopoiesis and Hematologic Malignancies.
Rossello-Tortella M, Ferrer G, Esteller M
Blood Cancer Discov. 2021; 1(1):26-31.
PMID: 34661141
PMC: 8447282.
DOI: 10.1158/2643-3249.BCD-20-0032.
Regulatory role and mechanism of mA RNA modification in human metabolic diseases.
Zhang Y, Chen W, Zheng X, Guo Y, Cao J, Zhang Y
Mol Ther Oncolytics. 2021; 22:52-63.
PMID: 34485686
PMC: 8399361.
DOI: 10.1016/j.omto.2021.05.003.
m6A RNA Methylation in Systemic Autoimmune Diseases-A New Target for Epigenetic-Based Therapy?.
Wardowska A
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33807762
PMC: 8001529.
DOI: 10.3390/ph14030218.
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.
Stuani L, Sabatier M, Saland E, Cognet G, Poupin N, Bosc C
J Exp Med. 2021; 218(5).
PMID: 33760042
PMC: 7995203.
DOI: 10.1084/jem.20200924.
